Compare Abeona Therapeutics Inc (ABEO) vs S&P500 ETF (SPY) Price & Performance

Abeona Therapeutics IncTrade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs S&P500 ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while S&P500 ETF trades at $772.15. Which is the better fit depends on your goals.

	ABEO	SPY
Market Cap	$421.19M	—
Sector	Health	—
52-Week High	$7.45	$773.22
52-Week Low	$4.17	$631.99
Enterprise Value	$276.10M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABEO

View details →

SPY

SPYI ETF offers high tax-free yield but with high fees and capped upside in Roth IRAs.24/7 Wall Street · 17 hours agoBearish Hyperscalers ramp up AI spending betting on AGI, but risks and doubts remain high.Seeking Alpha · 1 day agoNeutral Vanguard High Dividend Yield ETF lags S&P 500 by $141K over 10 years despite dividends.24/7 Wall Street · 1 day agoBearish View details →

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.